These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28774412)

  • 1. Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon.
    Ghany MG
    Best Pract Res Clin Gastroenterol; 2017 Jun; 31(3):299-309. PubMed ID: 28774412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B.
    Liang KH; Hsu CW; Chang ML; Chen YC; Lai MW; Yeh CT
    J Infect Dis; 2016 Mar; 213(6):966-74. PubMed ID: 26582959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
    Viganò M; Mangia G; Lampertico P
    Liver Int; 2014 Feb; 34 Suppl 1():120-6. PubMed ID: 24373088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis.
    Boettler T; Thimme R
    Dig Dis; 2015; 33(4):608-12. PubMed ID: 26159281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Buster EH; Schalm SW; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chemotherapy prevent HBV-related hepatocellular carcinoma? Pros.
    Liaw YF
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S293-7. PubMed ID: 20547317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Hepatitis B Infection: A Review.
    Tang LSY; Covert E; Wilson E; Kottilil S
    JAMA; 2018 May; 319(17):1802-1813. PubMed ID: 29715359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B.
    Cornberg M; Jaroszewicz J; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2010 Dec; 56(4):451-65. PubMed ID: 21139543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs.
    Janssen HL; Lau GK
    Hepatology; 2005 Dec; 42(6):1459; author reply 1459-60. PubMed ID: 16317685
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: current antiviral therapy of chronic hepatitis B.
    Ayoub WS; Keeffe EB
    Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons.
    Colombo M
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S298-301. PubMed ID: 20547318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?
    Buti M
    Liver Int; 2014 Feb; 34 Suppl 1():108-11. PubMed ID: 24373086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of therapy on the outcome of chronic hepatitis B.
    Liaw YF
    Liver Int; 2013 Feb; 33 Suppl 1():111-5. PubMed ID: 23286854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Okada M; Enomoto M; Kawada N; Nguyen MH
    Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1095-1104. PubMed ID: 28752768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roadmap to functional cure of chronic hepatitis B: An expert consensus.
    Ning Q; Wu D; Wang GQ; Ren H; Gao ZL; Hu P; Han MF; Wang Y; Zhang WH; Lu FM; Wang FS
    J Viral Hepat; 2019 Oct; 26(10):1146-1155. PubMed ID: 31087479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?
    Rijckborst V; Sonneveld MJ; Janssen HL
    Aliment Pharmacol Ther; 2011 Mar; 33(5):501-13. PubMed ID: 21198707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.
    Coffin CS; Rezaeeaval M; Pang JX; Alcantara L; Klein P; Burak KW; Myers RP
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1262-9. PubMed ID: 25312649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.